According to the report published by Allied Market Research, the global Anti-rheumatics market held nearly $57.22 billion in 2018, and is expected to generate $71.93 billion by 2026, registering a CAGR of 2.9% from 2019 to 2026. The research provides a detailed analysis of changing dynamics, recent trends, key segments, major winning strategies, and competitive landscape.
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
Key market players analyzed in the research include Pfizer, Inc., Bristol-Myers Squibb Company, Johnson & Johnsons, Celegene Corporations, F. Hoffmann-La Roche Ltd., Takeda Pharmaceutical Company Ltd., MedImmune, LLC, Celltrion Inc., Biogen Inc., and Amgen Inc.
Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/6289
Surge in rheumatoid arthritis incidence, increase in geriatric population, and increase in level of obesity across the globe fuel the growth of the global anti-rheumatics market. However, side effects regarding medication and expensive cost of biologics & biosimilars restrain the market growth. On the other hand, R&D activities taking place in biosimilars and innovative biologics create numerous opportunities in the market.
Scope of the Report:
| Report Attribute | Details |
| Market size available for years | 2018 – 2026 |
| Base year considered | 2019 |
| Forecast period | 2019 – 2026 |
| Forecast units | Value (USD) |
| Segments covered | By Drug Class, By Type |
| Geographies covered | North America, Europe, Asia-Pacific, LAMEA |
On the basis of drug class, the disease modifying anti-rheumatic drugs (DMARDs) segment accounted for more than one-third of the total share in 2018, and is estimated to maintain its leadership status throughout the forecast period. This is owing to its effects on medical conditions rather than symptoms. However, the nonsteroidal anti-inflammatory drugs (NSAIDs) segment would register the highest CAGR of 3.7% from 2019 to 2026.
Inquiry Before Purchase @ https://www.alliedmarketresearch.com/purchase-enquiry/6289
On the basis of type, the prescription-based drugs segment held the largest market share in the global anti-rheumatics market in 2018, accounting for more than three-fourths of the total market share in terms of revenue, and is expected to register its dominant position during the forecast period. This is due to rise in the number of specialized hospitals across the globe that offer treatments by specialized professionals. Contrarily, the over-the-counter drugs segment is expected to grow at the highest CAGR of 3.3% during the forecast period, owing to increase in awareness about treatment options and ease in accessibility.
Based on region, North America contributed to the largest share in 2018, contributing to nearly one-third of the global anti-rheumatics market, and is estimated to maintain its lead throughout the forecast period. This is due to ease in availability and rise in aging population susceptible to nephrological disorders. However, Asia-Pacific is expected to witness the highest growth rate with a CAGR of 3.7% from 2019 to 2026. This is due to rise in expenditure in healthcare and rise in awareness regarding anti-rheumatics.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
Related Reports:
Biosimilars Market Global Opportunity Analysis and Industry Forecast, 2014-2020
Metabolomics Market Global Opportunity Analysis and Industry Forecast, 2017-2023
Vaccines Market Global Opportunity Analysis and Industry Forecast, 2017-2023